Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

Biosimilars and beyond: innovating for improved patient outcomes

How Europe’s biosimilar landscape has rapidly evolved over the last two decades, bringing biological medicines to more patients than ever before

- PMLiVE

Gilead’s Trodelvy approved by FDA for metastatic breast cancer

HR+/HER2- is the most common type of breast cancer, accounting for 70% of new cases

- PMLiVE

World Health Organization releases new road map for breast cancer

Nearly 80% of breast and cervical cancer deaths occur in low- and middle-income countries

- PMLiVE

Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer

Endometrial cancer is the sixth most common cancer in women worldwide

- PMLiVE

Making new year resolutions that can also benefit others

Consider resolutions that could make 2023 a better year for many

- PMLiVE

ICR calls for improved biomarker cancer tests to help personalise treatment

Each cancer has a unique pattern of biomarkers that can affect how effective treatments are

- PMLiVE

AstraZeneca’s Imfinzi plus chemotherapy approved by MHRA for biliary tract cancer

Around 210,000 people worldwide are diagnosed with the disease each year

- PMLiVE

World Cancer Day: encouraging men to put their health first

A three-year campaign, running from 2022 to 2024, focuses on ‘Closing the Care Gap’

- PMLiVE

EIT Health marks World Cancer Day with €6m pledge for new healthcare delivery models

Endometrial cancer is the fourth most common cancer affecting women in the UK, with around 9,700 new cases every year

- PMLiVE

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines

Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients

- PMLiVE

Strategic behaviour

Strong strategising depends on your colleagues’ behaviour

- PMLiVE

Fishawack Health welcomes Mario Muredda as its new President of Marketing

Fishawack Health (FH) ushers in a new era of data-driven omnichannel marketing with the hire of healthcare marketing veteran Mario Muredda.

Avalere Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links